AMG 410 clinical trials

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

This study is looking at a new medicine, AMG 410, for cancers with a specific change called KRAS. We want to see how safe it is, how it works in the body, and if it helps shrink tumors, both on its own and with other medicines.